Farmacoeconomía aplicada en hematología
Año: 2014 Editorial: Instituto Max Weber Resúmen: Este es un libro dirigido, fundamentalmente a clínicos, en concreto hematólogos, que normalmente es la primera vez que se enfrentan a un texto de farmacoeconomía, por lo que se ha buscado el equilibrio de una exposición rigurosa desde el punto de vista económico que a la vez resulte […]
Innovación y regulación en biomedicina: obligados a entenderse
Año: 2017 Editorial: Fundacion Gaspar Casal Resumen: Néboa Zozaya, Directora del Área de Economía de la Salud, escribe el Capítulo 8 de este libro, titulado «Tecnologías para nacer y tecnologías para morir ¿cuál es el papel de los incentivos en la velocidad del proceso de adopción de las innovaciones?». Este capítulo está co-escrito por Beatriz […]
The Impact of Severe Obesity on Healthcare Resource Utilisation in Spain
Año: 2017 Revista: Obesity Surgery Resumen: la obesidad no es solo un problema de salud sino también una fuente de gastos en aumento. Los objetivos de este estudio fueron analizar el uso de los recursos sanitarios en la población adulta española con obesidad de clase II y superior (IMC ≥35 kg / m2) y compararla […]
An estimate of the cost of administering intravenous biological agents in Spanish day hospitals
Año: 2017 Revista: Therapeutics and Clinical Risk Management Resumen: to estimate the unit costs of administering intravenous (IV) biological agents in day hospitals (DHs) in the Spanish National Health System. Conclusion: The average total cost of infusion was less than that normally used in models of economic evaluation coming from secondary sources. This cost is even […]
Cost of vitamin K antagonist anticoagulant treatment in patients with metallic prosthetic valve in mitral position
Año: 2016 Revista: SAGE Open Medicine Resumen: the aim of this study was to examine the total healthcare costs of oral anticoagulant treatment with vitamin K antagonists in patients with metallic prosthetic valves in the mitral position. Cómo citar: Ene, G., Garcia Raso, A., Gonzalez-Dominguez Weber, A., Hidalgo-Vega, Á., & Llamas, P. (2016). Cost of vitamin […]
Long-term fiscal implications of funding assisted reproduction: a generational accounting model for Spain
Año: 2016 Revista: Reproductive Biomedicine and Society Resumen:The aim of this study was to assess the lifetime economic benefits of assisted reproduction in Spain by calculating the return on this investment. We developed a generational accounting model that simulates the flow of taxes paid by the individual, minus direct government transfers received over the individual’s lifetime. The difference between […]
Estimación del coste de administración de Rituximab para el tratamiento de Linfomas No Hodking en hospitales de día del SNS
CONGRESO: AES AÑO: 2015 ENFERMEDAD: Linfoma No Hodgkin TEMA: Estudio de costes SUBCATEGORÍA: Estudio observacional OBJETIVOS: estimar los costes unitarios de la administración intravenosa de Rituximab (MabThera®) para el tratamiento del Linfoma No Hodgkin en los hospitales de día del Sistema Nacional de Salud (SNS) español.
Direct vitamin k antagonist anticoagulant treatment health care costs in patients with non-valvular atrial fibrillation
Año: 2014 Revista: BMC Health Services Research Resumen: There is evidence suggesting that most thromboembolic complications could be prevented with adequate pharmacological anticoagulation. We estimated the direct health care costs of anticoagulant treatment with oral vitamin K antagonists in patients diagnosed with non-valvular atrial fibrillation. We collected data from 1,257 patients diagnosed with non-valvular atrial […]
Analysis of economic evaluations of pharmacological cancer treatments in Spain between 1990 and 2010
Año: 2013 Revista: Clinical and Translational Oncology Resumen: economic evaluation of pharmacological cancer treatment is a critical clinical problem currently under consideration worldwide. We have analysed their main characteristics in Spain between 1990 and 2010 following a systematic review of the 29 complete economic analyses published. The pathology most frequently evaluated was non-small cell lung […]